Merus N V (MRUS)

May 24, 2026

MerusFinancial Details - Crunchbase

May 24, 2026

May 21, 2026

Merus NV stock (NL0011375928): pipeline momentum and clinical updates keep biotech in focus - AD HOC NEWS

May 21, 2026

May 17, 2026

Merus NV stock (NL0011375928): biotech share jumps after solid Q1 data and outlook - AD HOC NEWS

May 17, 2026

May 16, 2026

Merus NV stock (NL0011375928): immuno-oncology player in focus after pipeline and data updates - AD HOC NEWS

May 16, 2026

May 14, 2026

Oculis Holding Ag Announces Board and Committee Changes - marketscreener.com

May 14, 2026

May 12, 2026

FDA Approval for BIZENGRI issued to MERUS N.V. - Quantisnow

May 12, 2026

May 11, 2026

TradingKey - TradingKey

May 11, 2026

May 07, 2026

Genmab Announces Financial Results for the First Quarter of 2026 - NTB Kommunikasjon

May 07, 2026

Apr 28, 2026

Merus N.V. announces proposed public offering of common shares - MSN

Apr 28, 2026

Apr 27, 2026

Merus Stock Soars To All-Time High As Genmab Announces $8B Takeover — Analysts Turn Cautious, Retail Crowd Cheers The Deal - MSN

Apr 27, 2026

Apr 27, 2026

Wells Fargo Downgrades Merus N.V. (MRUS) - MSN

Apr 27, 2026

Apr 25, 2026

Goldman's 48 potential M&A candidates - MSN

Apr 25, 2026

Apr 24, 2026

Merus (MRUS) Stifel 2024 Healthcare Conference Summary - Quartr

Apr 24, 2026

Apr 24, 2026

Merus (MRUS) Investor Update Summary - Quartr

Apr 24, 2026

Apr 24, 2026

Merus (MRUS) Proxy Filing Summary - Quartr

Apr 24, 2026

Apr 24, 2026

Merus (MRUS) TD Cowen 45th Annual Healthcare Conference Summary - Quartr

Apr 24, 2026

Apr 09, 2026

Portfolio Update: Will Merus NV benefit from rising consumer demandEarnings Growth Report & Reliable Breakout Stock Forecasts - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

GMAB SEC FilingsGenmab 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 08, 2026

Apr 08, 2026

Swing Trade: Is Merus NV exposed to currency risks2026 Momentum & Breakout Confirmation Trade Signals - baoquankhu1.vn

Apr 08, 2026

Mar 30, 2026

Trade Report: Is Merus NV on track to beat earnings2026 Short Interest & Daily Momentum Trading Reports - baoquankhu1.vn

Mar 30, 2026

Mar 28, 2026

Aug Weekly: Is Merus NV being accumulated by smart money2026 Analyst Calls & Fast Gaining Stock Strategy Reports - baoquankhu1.vn

Mar 28, 2026

Mar 27, 2026

US Market Wrap: What hedge funds are buying Merus NVInflation Watch & Reliable Intraday Trade Alerts - baoquankhu1.vn

Mar 27, 2026

Mar 26, 2026

Merus NV Stock: Genmab Acquisition Deal at $97 Per Share Reshapes Biotech Investment Landscape for N - AD HOC NEWS

Mar 26, 2026

Mar 25, 2026

Bank Watch: Is Merus NV on track to beat earningsWeekly Investment Report & Capital Efficiency Focused Strategies - baoquankhu1.vn

Mar 25, 2026

Mar 21, 2026

Bull Run: Can Merus NV reach all time highs this year2026 Buyback Activity & Safe Entry Zone Tips - baoquankhu1.vn

Mar 21, 2026

Mar 17, 2026

Genmab Agrees to Buy Cancer Drugmaker Merus for $8 Billion - MSN

Mar 17, 2026

Mar 17, 2026

Stock Recap: Can Merus NV reach all time highs this yearRate Hike & Target Return Focused Stock Picks - baoquankhu1.vn

Mar 17, 2026

Mar 15, 2026

Merus NV Stock (ISIN: NL0011375928) Gains Momentum on Bispecific Antibody Pipeline Progress - AD HOC NEWS

Mar 15, 2026

Mar 14, 2026

Merus Buyout Rumor Gets Retail Traders Buzzing — Genmab Said To Be Leading The Race - MSN

Mar 14, 2026

Mar 11, 2026

Growth Review: Is Merus NV a good ESG investment2026 Setups & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Mar 11, 2026

Mar 09, 2026

Precision Trading with Merus N.v. (MRUS) Risk Zones - Stock Traders Daily

Mar 09, 2026

Mar 06, 2026

How Merus N.V. stock reacts to bond yieldsTrade Analysis Report & Low Risk Profit Maximizing Plans - Naître et grandir

Mar 06, 2026

Mar 05, 2026

Dividend Watch: Is Merus NV being accumulated by smart moneyMarket Sentiment Review & Consistent Profit Trade Alerts - baoquankhu1.vn

Mar 05, 2026

Feb 25, 2026

Merus N.V. (MRUS) Stock Analysis: Potential Upside In The Biotech Sector - DirectorsTalk Interviews

Feb 25, 2026

Feb 24, 2026

Aug Summary: Is Merus NV a good ESG investment2025 Big Picture & Short-Term Trading Opportunity Alerts - baoquankhu1.vn

Feb 24, 2026

Feb 17, 2026

Merus N.V. (MRUS) Stock Analysis: Biotechnology Gem With 7.78% Potential Upside - DirectorsTalk Interviews

Feb 17, 2026

Feb 17, 2026

Genmab Publishes 2025 Annual Report - GlobeNewswire

Feb 17, 2026

Feb 16, 2026

Bank of America Securities Maintained a Buy Rating on Merus N.V (MRUS) - MSN

Feb 16, 2026

Feb 16, 2026

What is Merus N.V. s 5 year growth outlookWeekly Stock Summary & AI Enhanced Trading Signals - mfd.ru

Feb 16, 2026

Feb 13, 2026

Targets Report: Will Merus N.V. stock outperform tech sector in 2025Weekly Trade Summary & Reliable Momentum Entry Alerts - mfd.ru

Feb 13, 2026

Feb 12, 2026

Genmab Prepares For Two Product Launches In 2027, Both From Recent Deals - Citeline News & Insights

Feb 12, 2026

Feb 10, 2026

Is Merus N.V. stock trading near support levelsJuly 2025 PostEarnings & Intraday High Probability Setup Alerts - mfd.ru

Feb 10, 2026

Feb 10, 2026

Published on: 2026-02-10 12:58:35 - mfd.ru

Feb 10, 2026

Feb 06, 2026

Can Merus N.V. reach all time highs this year2025 Major Catalysts & Proven Capital Preservation Methods - mfd.ru

Feb 06, 2026

Feb 03, 2026

Merus N.V. (MRUS) Stock Analysis: Weighing The 7.78% Potential Upside For Investors - DirectorsTalk Interviews

Feb 03, 2026

Jan 27, 2026

Merus N.V. (MRUS) Stock Analysis: Exploring the Potential 7.78% Upside in the Biotech Sector - DirectorsTalk Interviews

Jan 27, 2026

Jan 25, 2026

Analyst Downgrade: Is Merus NV gaining market shareJuly 2025 Macro Moves & Daily Stock Momentum Reports - baoquankhu1.vn

Jan 25, 2026

Jan 25, 2026

Growth Recap: What are Can Fite BioPharma Ltd Depositary Receipts technical support levels - baoquankhu1.vn

Jan 25, 2026

Jan 24, 2026

Aug Ideas: Is Merus NV a turnaround storyJuly 2025 PreEarnings & AI Enhanced Execution Alerts - baoquankhu1.vn

Jan 24, 2026

Jan 21, 2026

Fourteen option delistings on January 21st - TipRanks

Jan 21, 2026

Jan 20, 2026

Merus N.V. (MRUS) Stock Analysis: Biotechnology Innovator With 7.78% Upside Potential - DirectorsTalk Interviews

Jan 20, 2026